Your session is about to expire
← Back to Search
Investigational Drug for Spinocerebellar Ataxia (STRIDES Trial)
STRIDES Trial Summary
This trial is testing a new drug to see if it is safe and effective for treating adults with spinocerebellar ataxia, a degenerative neurological disorder.
STRIDES Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSTRIDES Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STRIDES Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your body mass index (BMI) falls between 18 and 35 kilograms per square meter.I am between 18 and 75 years old.If you have any other medical condition or issue that could make it hard for the study team to collect accurate safety or effectiveness data or might put you at risk during the study, you may not be able to participate.I have been genetically confirmed to have SCA3.You have a score of 4 or more on a test that measures your symptoms.I have never been treated with SLS-005 or similar drugs, nor am I allergic to trehalose.I have had liver injury from medication or my liver tests are not normal.Your body mass index (BMI) falls between 18 and 35.I do not have any significant heart problems that could make participating unsafe.My kidney function is not adequate, with a creatinine clearance of less than 60 mL/min.I am willing to follow the study's rules on sexual activity or birth control.My medication doses have been the same for the last 30 days.I have been diagnosed with or am being treated for type 1 or type 2 diabetes.I have chronic liver disease or HIV, or I had Hepatitis B or C but it was successfully treated.You have a history of abusing drugs or alcohol within the past two years.You scored 4 or higher on a test called m-SARA during the screening visit.My ataxia is not genetically confirmed as SCA type 3 and is not due to conditions like alcoholism or head injury.You are not currently participating in another clinical trial or completed one less than 30 days ago (90 days if it involved a biological treatment).You have answered "yes" to questions about suicidal thoughts or behavior in the past 6 months or 3 years on a test called the Columbia Suicide Severity Rating Scale (C-SSRS).I am between 18 and 75 years old.I have been genetically confirmed to have SCA3.You have a mental or cognitive disorder that might affect your ability to understand the study or complete the necessary assessments.
- Group 1: SLS-005 0.75 g/kg Dose
- Group 2: SLS-005 0.50 g/kg Dose
- Group 3: Placebo volume equivalent to a SLS-005 0.75 g/kg dose calculation
- Group 4: Placebo volume equivalent to a SLS-005 0.50 g/kg dose calculation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the highest number of people who can enroll in this research project?
"Yes, this is an ongoing trial that is still recruiting patients, as of October 11th, 2022. The trial was first posted on June 3rd, 2022 and is looking for 245 patients total, at 7 different sites."
Are individuals who are over the age of 30 allowed to participate in this research project?
"This particular clinical trial requires that applicants are aged 18 to 75. While there are 19 clinical trials for patients that are younger and 33 for patients that are older, this is the only study with these age requirements."
Are there any specific patients this study is designed for?
"The researchers conducting this trial are looking for 245 individuals that have spinocerebellar ataxia type 3 and are between 18-75 years old. The applicants must also meet the following requirements: Be able to provide informed consent, be of either gender, have a BMI between 18-35 kg/m2, have been taking the same doses of medication for the past 30 days, have a negative pregnancy test for female participants of childbearing potential, and be willing to comply with sexual abstinence or contraception guidelines."
Are participants being sought for this experiment currently?
"That is correct, the online information specifies that the clinical trial is looking for enrollees. The trial was first posted on June 3rd, 2022 and was last updated on October 11th, 2022. There is a need for 245 patients at 7 sites."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of South Florida: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger